Ten pharmaceutical companies, including Amgen, have donated almost $54 million to oppose Proposition 61, a ballot initiative that proponents say would stop price gouging on prescriptions. A Business Times analysis also shows the Thousand Oaks-based company donated more than $190,000 over the past two years to members of three congressional panels whose hearings questioned pharmaceutical…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
